Literature DB >> 1522151

Interference in vimentin assembly in vitro by synthetic peptides derived from the vimentin head domain.

I Hofmann1, H Herrmann.   

Abstract

The importance of the amino-terminal domain ("head") of type III intermediate filament (IF) proteins in IF assembly has been examined by testing the influence of synthetic peptides representing a highly conserved decameric motif, KSSSYRRIMFGG, located near the amino terminus of vimentin. When added to soluble vimentin subunits this peptide induces, at fourfold molar excess or slightly above, the appearance of short, regular rod-like structures as determined by electron microscopy of negatively stained and rotary-shadowed preparations as well as by viscometry. At higher peptide concentrations large, irregularly shaped aggregates of mostly non-IF structures formed, but this aggregation was reversible by prolonged dialysis against low ionic strength buffer. The aggregating effect of this peptide was highly sequence-specific and was not seen with point-mutated sequences such as RR----TR or with unrelated peptides containing a central diarginine, indicating that it is not simply ionic. When different hexapeptides representing different "head" positions were compared, only the central sequence, SYRRXF, was as effective as the decamer. The addition of peptide during IF assembly did not prevent filament formation, although 50-fold molar excess of peptide resulted in a drastic increase (up to 40 nm) in the width of the filaments, which also appeared less regular, thus reflecting some interference with assembly. In contrast to the effects on soluble vimentin, the decameric peptide did not disturb IFs, indicating that the binding domain is "masked" or stabilized in the filaments. To identify the domain to which the peptide binds, three different binding assays using vimentin fragments and genetically engineered vimentin deletion mutants were employed. The results indicate that the binding domain of the near-amino-terminal peptide is located at the start of the alpha-helical "rod" domain of the protein. Possible mechanisms of interaction of these two portions of vimentin during IF assembly are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522151     DOI: 10.1242/jcs.101.3.687

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Site-directed spin labeling and electron paramagnetic resonance determination of vimentin head domain structure.

Authors:  Atya Aziz; John F Hess; Madhu S Budamagunta; John C Voss; Paul G FitzGerald
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

Review 2.  Intermediate filaments as dynamic structures.

Authors:  M W Klymkowsky
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly.

Authors:  Saima Usman; Hebah Aldehlawi; Thuan Khanh Ngoc Nguyen; Muy-Teck Teh; Ahmad Waseem
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

4.  The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation.

Authors:  S Heins; P C Wong; S Müller; K Goldie; D W Cleveland; U Aebi
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

5.  Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3.

Authors:  Pengfei Liu; Shengwei Zhang; Jingyi Ma; Dongning Jin; Yali Qin; Mingzhou Chen
Journal:  PLoS Pathog       Date:  2022-09-15       Impact factor: 7.464

6.  Bovine filensin possesses primary and secondary structure similarity to intermediate filament proteins.

Authors:  F Gounari; A Merdes; R Quinlan; J Hess; P G FitzGerald; C A Ouzounis; S D Georgatos
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

7.  The roles of K5 and K14 head, tail, and R/K L L E G E domains in keratin filament assembly in vitro.

Authors:  A K Wilson; P A Coulombe; E Fuchs
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.